Display options
Share it on

Clin Rev Allergy Immunol. 2017 Apr;52(2):273-286. doi: 10.1007/s12016-016-8592-1.

Beyond Genetics: What Causes Type 1 Diabetes.

Clinical reviews in allergy & immunology

Zhen Wang, Zhiguo Xie, Qianjin Lu, Christopher Chang, Zhiguang Zhou

Affiliations

  1. Diabetes Center, 2nd Xiangya Hospital, and Institute of Metabolism and Endocrinology, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, 139 Renmin Middle Rd, Changsha, Hunan, 410011, China.
  2. Department of Dermatology, 2nd Xiangya Hospital, Central South University, Hunan Key Laboratory of Medical Epigenomics, 139 Renmin Middle Rd, Changsha, Hunan, 410011, China.
  3. Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, Davis, CA, USA.
  4. Diabetes Center, 2nd Xiangya Hospital, and Institute of Metabolism and Endocrinology, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, 139 Renmin Middle Rd, Changsha, Hunan, 410011, China. [email protected].

PMID: 27878451 DOI: 10.1007/s12016-016-8592-1

Abstract

Type 1 diabetes (T1D) is an autoimmune disease resulting from T cell-mediated β cell destruction in the pancreas of genetically susceptible individuals. Extensive familial and population genetic studies uncovered the strong linkage and association between HLA gene variants and T1D. Non-HLA genes have also been associated with T1D, such as INS, CTLA4, and PTPN22. T1D is considered as one of the most heritable common diseases. However, evidence that monozygotic twins have incomplete concordance of disease susceptibility provides convincing proof that environmental factors also play important roles in the pathogenesis of the disease. Environmental factors can induce the alterations of gene expression via epigenetic mechanisms. Epigenetic modifications refer to the alterations in gene expression without changes of the DNA sequence, but instead occur as a result of DNA methylation, histone modifications, and miRNA regulation. Aberrant epigenetic modifications will cause the dysregulation of gene expression, thus leading to a variety of human diseases. There are significant differences in DNA methylation, histone modifications, and miRNA profiling found in T1D patients compared with healthy individuals. Epigenetic modifications contribute to the pathogenesis of T1D mainly by regulating the expression of susceptible genes in T1D. These susceptible genes are involved in antigen presentation (such as HLA), immune tolerance (such as FOXP3 and CTLA4), autoreactive T cell response (such as GAD65), and β cell functions (such as INS). A better understanding of epigenetic mechanisms for regulating susceptible genes of T1D will help identify candidates that target epigenetic pathways to control and/or prevent T1D. Knowledge of epigenetic changes in T1D also provides us with potential biomarkers for diagnosis, prognostication, personalized treatment, and prevention of the disease.

Keywords: DNA methylation; Environmental factors; Epigenetics; Genetics; Histone modifications; Type 1 diabetes; miRNA

References

  1. Lancet. 1974 Nov 30;2(7892):1279-83 - PubMed
  2. Diabetes. 2008 Dec;57(12):3189-98 - PubMed
  3. Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):263-70 - PubMed
  4. Nature. 2008 Oct 23;455(7216):1109-13 - PubMed
  5. J Environ Sci Health B. 1988 Oct;23 (5):427-38 - PubMed
  6. J Rheumatol. 2008 May;35(5):804-10 - PubMed
  7. J Autoimmun. 2016 Jul;71:1-9 - PubMed
  8. Arthritis Res Ther. 2010;12(3):R81 - PubMed
  9. Arthritis Rheum. 2009 Apr;60(4):1065-75 - PubMed
  10. Diabetes. 2010 Apr;59(4):978-86 - PubMed
  11. Arthritis Rheum. 1990 Nov;33(11):1665-73 - PubMed
  12. J Autoimmun. 2016 Aug;72 :47-56 - PubMed
  13. Diabetes Metab Res Rev. 2011 Jan;27(1):70-8 - PubMed
  14. Nature. 2007 Dec 6;450(7171):887-92 - PubMed
  15. J Biochem Toxicol. 1994 Apr;9(2):97-106 - PubMed
  16. Arthritis Rheum. 2011 May;63(5):1376-86 - PubMed
  17. Clin Rev Allergy Immunol. 2014 Oct;47(2):174-92 - PubMed
  18. Diabetes Care. 2015 Jan;38(1):16-21 - PubMed
  19. Immunobiology. 2013 May;218(5):733-7 - PubMed
  20. Diabetologia. 2007 Jan;50(1):68-73 - PubMed
  21. J Immunol. 2007 Nov 1;179(9):6352-8 - PubMed
  22. J Autoimmun. 2016 Jul;71:10-8 - PubMed
  23. Arthritis Rheum. 2002 May;46(5):1282-91 - PubMed
  24. Nat Biotechnol. 2010 Oct;28(10):1057-68 - PubMed
  25. Diabetes. 2012 Jul;61(7):1742-51 - PubMed
  26. J Autoimmun. 2016 Jan;66:76-88 - PubMed
  27. J Biol Chem. 2012 May 11;287(20):16335-45 - PubMed
  28. In Vitro. 1983 Jan;19(1):25-30 - PubMed
  29. Immunol Lett. 2011 Sep 30;139(1-2):80-6 - PubMed
  30. J Autoimmun. 2016 Jul;71:69-77 - PubMed
  31. Autoimmun Rev. 2010 Mar;9(5):A355-65 - PubMed
  32. Diabetes Metab Res Rev. 2011 Nov;27(8):862-6 - PubMed
  33. J Autoimmun. 2013 Mar;41:1-5 - PubMed
  34. J Immunol. 2005 May 15;174(10):6212-9 - PubMed
  35. Cell Immunol. 2012 Nov;280(1):16-21 - PubMed
  36. Nat Clin Pract Endocrinol Metab. 2007 Jan;3(1):36-45; quiz 2p following 69 - PubMed
  37. Ann Rheum Dis. 2011 Aug;70(8):1496-506 - PubMed
  38. J Autoimmun. 2006 Sep;27(2):89-95 - PubMed
  39. J Autoimmun. 2016 Jul;71:44-50 - PubMed
  40. J Autoimmun. 2016 Apr;68:23-9 - PubMed
  41. Chin Med J (Engl). 2009 Apr 20;122(8):980-6 - PubMed
  42. Immunology. 2008 Oct;125(2):161-9 - PubMed
  43. Diabetes Care. 2001 Aug;24(8):1460-7 - PubMed
  44. J Autoimmun. 2016 Sep;73:54-63 - PubMed
  45. Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12030-5 - PubMed
  46. Environ Health Perspect. 2001 Dec;109 Suppl 6:871-6 - PubMed
  47. J Autoimmun. 2014 May;50:33-7 - PubMed
  48. J Exp Med. 2001 Jun 4;193(11):F41-6 - PubMed
  49. J Autoimmun. 2014 Sep;53:85-94 - PubMed
  50. Diabetes. 2013 Feb;62(2):543-50 - PubMed
  51. Diabetologia. 2012 Aug;55(8):2142-7 - PubMed
  52. Cold Spring Harb Perspect Med. 2012 Jan;2(1):a007732 - PubMed
  53. PLoS Genet. 2011 Sep;7(9):e1002300 - PubMed
  54. N Engl J Med. 2000 Feb 3;342(5):301-7 - PubMed
  55. Ann N Y Acad Sci. 2006 Oct;1079:24-30 - PubMed
  56. BMC Med Genomics. 2010 Aug 05;3:33 - PubMed
  57. Diabetes Metab Res Rev. 2007 Mar;23(3):169-83 - PubMed
  58. Diabetes. 1999 May;48(5):983-8 - PubMed
  59. Diabetes Res Clin Pract. 2011 Nov;94(2):242-8 - PubMed
  60. Diabet Med. 2009 Feb;26(2):182-6 - PubMed
  61. PLoS One. 2016 Apr 25;11(4):e0152662 - PubMed
  62. J Autoimmun. 2017 Jan;76:63-74 - PubMed
  63. Nat Genet. 2009 Feb;41(2):178-186 - PubMed
  64. Diabetes. 2015 Nov;64(11):3867-72 - PubMed
  65. Immunol Cell Biol. 2011 Jul;89(5):640-9 - PubMed
  66. Diabetes Care. 2008 Aug;31(8):1608-10 - PubMed
  67. Diabetes. 2010 Jul;59(7):1561-71 - PubMed
  68. Diabetes. 2009 May;58(5):1229-36 - PubMed
  69. Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14580-5 - PubMed
  70. Diabetes Res Clin Pract. 2007 Apr;76(1):126-31 - PubMed
  71. Neuroimmunomodulation. 2006;13(5-6):301-8 - PubMed
  72. J Autoimmun. 2010 May;34(3):J207-19 - PubMed
  73. J Autoimmun. 2016 Jul;71:51-8 - PubMed
  74. Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):19018-23 - PubMed
  75. Arthritis Rheum. 2008 Sep;58(9):2686-93 - PubMed
  76. J Autoimmun. 2016 Apr;68:52-61 - PubMed
  77. Diabetologia. 2004 Jul;47(7):1285-1291 - PubMed
  78. Arthritis Rheum. 2006 Mar;54(3):779-87 - PubMed
  79. Pediatrics. 2013 Dec;132(6):1112-22 - PubMed
  80. PLoS One. 2012;7(5):e36278 - PubMed
  81. J Autoimmun. 2016 Aug;72 :113-7 - PubMed
  82. Cell. 2004 Jan 23;116(2):281-97 - PubMed
  83. Pediatr Diabetes. 2002 Dec;3(4):184-8 - PubMed
  84. J Immunol. 2010 Jun 15;184(12):6773-81 - PubMed
  85. J Autoimmun. 2016 Jul;71:59-68 - PubMed
  86. Tissue Antigens. 2007 Aug;70(2):110-27 - PubMed
  87. J Immunol. 2003 May 15;170(10):5124-32 - PubMed
  88. Diabetes. 2002 Feb;51(2):545-51 - PubMed
  89. J Autoimmun. 2016 Aug;72 :118-25 - PubMed
  90. Diabetes Metab Res Rev. 2013 Jan;29(1):8-18 - PubMed
  91. Inflamm Res. 2008 Jan;57(1):4-10 - PubMed
  92. J Autoimmun. 2017 Jan;76:115-122 - PubMed
  93. Diabetes. 2011 Oct;60(10):2645-53 - PubMed
  94. N Engl J Med. 1986 May 22;314(21):1360-8 - PubMed
  95. Diabetologia. 2016 May;59(5):1021-9 - PubMed
  96. Autoimmun Rev. 2014 Apr-May;13(4-5):403-7 - PubMed
  97. Diabetes. 1986 Feb;35(2):237-41 - PubMed
  98. Discov Med. 2011 Dec;12(67):535-45 - PubMed
  99. Trends Mol Med. 2008 Jun;14 (6):268-75 - PubMed
  100. J Autoimmun. 2016 Jul;71:88-96 - PubMed
  101. Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S116-21 - PubMed
  102. Scand J Immunol. 2012 Feb;75(2):129-41 - PubMed
  103. ISRN Pharmacol. 2012;2012:580202 - PubMed
  104. J Autoimmun. 2016 Sep;73:130 - PubMed
  105. PLoS One. 2014 Apr 10;9(4):e94591 - PubMed
  106. Diabetes Care. 1995 Jan;18(1):47-55 - PubMed
  107. Diabetes Care. 2003 Aug;26(8):2345-52 - PubMed
  108. Cell. 2007 Feb 23;128(4):669-81 - PubMed
  109. Cell Immunol. 2010;260(2):70-4 - PubMed
  110. Can J Diabetes. 2016 Dec;40(6):586-593 - PubMed
  111. Prim Care Diabetes. 2008 Sep;2(3):121-6 - PubMed
  112. J Autoimmun. 2016 Jul;71:19-25 - PubMed
  113. PLoS One. 2013 Jul 12;8(7):e68093 - PubMed
  114. J Diabetes. 2015 Mar;7(2):158-65 - PubMed
  115. Mt Sinai J Med. 2008 Aug;75(4):314-27 - PubMed
  116. Endocrinol Metab Clin North Am. 2010 Sep;39(3):481-97 - PubMed
  117. J Autoimmun. 2013 Mar;41:50-9 - PubMed
  118. Lab Invest. 2015 Dec;95(12):1387-97 - PubMed
  119. J Autoimmun. 2016 Nov;74:176-181 - PubMed
  120. Endocrinology. 2013 Feb;154(2):603-8 - PubMed
  121. Arch Environ Health. 2002 Sep-Oct;57(5):412-5 - PubMed
  122. J Autoimmun. 2007 Jun;28(4):177-87 - PubMed
  123. Endocrinology. 2013 Sep;154(9):3476-81 - PubMed
  124. Ann N Y Acad Sci. 2008 Dec;1150:99-102 - PubMed
  125. Endocr Rev. 1994 Aug;15(4):516-42 - PubMed
  126. Blood. 2003 Feb 15;101(4):1430-8 - PubMed
  127. J Cell Biochem. 2009 Jul 1;107(4):600-8 - PubMed
  128. Arthritis Rheum. 2004 Oct;50(10):3365-76 - PubMed
  129. Exp Diabetes Res. 2012;2012:896362 - PubMed
  130. Arthritis Rheum. 2009 Dec;60(12):3613-22 - PubMed
  131. Arthritis Rheum. 2012 Sep;64(9):2953-63 - PubMed

MeSH terms

Publication Types